Inhibition of varicella-zoster virus by penciclovir in cell culture and mechanism of action

被引:16
作者
Bacon, TH [1 ]
Gilbart, J [1 ]
Howard, BA [1 ]
StandringCox, R [1 ]
机构
[1] SMITHKLINE BEECHAM PHARMACEUT,BETCHWORTH RH3 7AJ,SURREY,ENGLAND
关键词
aciclovir; cell culture; penciclovir; varicella-zoster virus;
D O I
10.1177/095632029600700203
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effect of penciclovir (BRL 39123) on the replication of varicella-zoster virus (VZV) in human embryonic lung fibroblasts (MRC-B cells) was similar to aciclovir when the compounds were present continuously, However, when the compounds were withdrawn the antiviral activity of penciclovir was maintained more effectively than that of aciclovir. In the plaque reduction assay, median 50% effective concentrations (EC(50)s) were 3.8 mu g mi(-1) for penciclovir and 4.2 mu g ml(-1) for aciclovir (n = 29 clinical isolates), Similarly, penciclovir and aciclovir were equally effective in reducing the numbers of VZV-infected MRC-5 cells and in reducing VZV DNA synthesis within infected cells following continuous treatment, Within VZV-infected cells (S)-penciclovir-triphosphate was formed from penciclovir with >95% enantiomeric purity, and the concentration of penciclovir-triphosphate was 360-fold greater than aciclovir-triphosphate immediately after treatment, This phosphorylation ratio compensates for the lower affinity of VZV DNA polymerase for penciclovir-triphosphate compared with aciclovir-triphosphate (K(i)s = 7.5 mu M and 0.2 mu M, respectively), When VZV-infected cultures were treated for 3 days, followed by withdrawal of the compound, inhibition of viral DNA synthesis by penciclovir was maintained for 24 h, whereas viral DNA synthesis resumed more readily after removal of aciclovir. Furthermore, following 8 h daily pulse treatment for 5 days, penciclovir was significantly more active than aciclovir in reducing VZV DNA synthesis (p = 0.006, n = 10 clinical isolates), The long intracellular half-life of penciclovir-triphosphate (9.1 h) compared with that of aciclovir-triphosphate (0.8 h) accounts for the sustained inhibition of virus replication by penciclovir, This property may contribute to the clinical efficacy of famciclovir, the oral form of penciclovir.
引用
收藏
页码:71 / 78
页数:8
相关论文
共 21 条
[1]   AN OVERVIEW OF THE FURTHER EVALUATION OF PENCICLOVIR AGAINST HERPES-SIMPLEX VIRUS AND VARICELLA-ZOSTER VIRUS IN CELL-CULTURE HIGHLIGHTING CONTRASTS WITH ACYCLOVIR [J].
BACON, TH ;
SCHINAZI, RF .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1993, 4 :25-36
[2]   PENCICLOVIR - A REVIEW OF ITS SPECTRUM OF ACTIVITY, SELECTIVITY, AND CROSS-RESISTANCE PATTERN [J].
BOYD, MR ;
SAFRIN, S ;
KERN, ER .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1993, 4 :3-11
[3]   ANTIHERPESVIRUS ACTIVITY OF 9-(4-HYDROXY-3-HYDROXYMETHYLBUT-1-YL)GUANINE (BRL-39123) IN CELL-CULTURE [J].
BOYD, MR ;
BACON, TH ;
SUTTON, D ;
COLE, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (08) :1238-1242
[4]  
COLLINS P, 1977, NY ACAD SCI, V284, P49
[5]   FAMCICLOVIR, A NEW ORAL ANTIHERPES DRUG - RESULTS OF THE FIRST CONTROLLED CLINICAL-STUDY DEMONSTRATING ITS EFFICACY AND SAFETY IN THE TREATMENT OF UNCOMPLICATED HERPES-ZOSTER IN IMMUNOCOMPETENT PATIENTS [J].
DEGREEF, H ;
ANDREJEVIC, L ;
AOKI, F ;
AREND, J ;
ASHTON, R ;
DEBACKER, W ;
BARTLETT, K ;
VANBLOKLAND, WB ;
BISHOP, S ;
BOON, R ;
BORBUJO, J ;
CALZ, AM ;
CANDAELE, M ;
COLLINS, P ;
CRAWFORD, G ;
CVIJETIC, O ;
DECROIX, J ;
DECUYPER, C ;
DELESCLUSE, J ;
DEMAUBEUGE, J ;
DUSCHET, P ;
FRANSEN, H ;
FRENK, E ;
FRITSCH, P ;
GHEERAERT, P ;
GOETIJN, M ;
GONZALEZ, A ;
GOOSSEN, J ;
GRCIC, R ;
GRIFFIN, D ;
GSCHNAIT, F ;
HANSSENS, Y ;
HARMS, M ;
HOSANG, M ;
ILIC, V ;
ISENBERG, Y ;
JANSEN, A ;
JONES, S ;
JOVOVIC, D ;
KRAFFT, T ;
KRANENDONK, H ;
LALOSEVIC, J ;
LEEN, C ;
MARCIAS, M ;
MCGOUGALL, B ;
MCKENDRICK, M ;
MILOJEVIC, M ;
NABER, F ;
NELEMANS, F ;
NYE, F .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1994, 4 (04) :241-246
[6]   MODE OF ANTIVIRAL ACTION OF PENCICLOVIR IN MRC-5 CELLS INFECTED WITH HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1), HSV-2, AND VARICELLA-ZOSTER VIRUS [J].
EARNSHAW, DL ;
BACON, TH ;
DARLISON, SJ ;
EDMONDS, K ;
PERKINS, RM ;
HODGE, RAV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) :2747-2757
[7]   A COMPARATIVE-STUDY OF THE IN-VITRO AND IN-VIVO ANTIVIRAL ACTIVITIES OF ACYCLOVIR AND PENCICLOVIR [J].
ERTL, P ;
SNOWDEN, W ;
LOWE, D ;
MILLER, W ;
COLLINS, P ;
LITTLER, E .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1995, 6 (02) :89-97
[8]   NUCLEIC-ACID HYBRIDIZATION, A METHOD TO DETERMINE EFFECTS OF ANTIVIRAL COMPOUNDS ON HERPES-SIMPLEX VIRUS TYPE-1 DNA-SYNTHESIS [J].
GADLER, H ;
LARSSON, A ;
SOLVER, E .
ANTIVIRAL RESEARCH, 1984, 4 (1-2) :63-70
[9]   THE MODE OF ACTION OF PENCICLOVIR [J].
HODGE, RAV ;
CHENG, YC .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1993, 4 :13-24
[10]   MODE OF ACTION OF 9-(4-HYDROXY-3-HYDROXYMETHYLBUT-1-YL)GUANINE (BRL 39123) AGAINST HERPES-SIMPLEX VIRUS IN MRC-5 CELLS [J].
HODGE, RAV ;
PERKINS, RM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (02) :223-229